Attached files

file filename
EX-31.2 - EXHIBIT 31.2 - Anika Therapeutics, Inc.exh_312.htm
EX-31.1 - EXHIBIT 31.1 - Anika Therapeutics, Inc.exh_311.htm
EX-10.1 - EXHIBIT 10.1 - Anika Therapeutics, Inc.exh_101.htm
10-Q - FORM 10-Q - Anika Therapeutics, Inc.f10q_073118p.htm

Exhibit 32.1


Section 906 Certification


The undersigned officers of Anika Therapeutics, Inc. (the “Company”) hereby certify to their knowledge and in their respective capacities that the Company’s quarterly report on Form 10-Q to which this certification is attached (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date: July 31, 2018
  Joseph G. Darling.
  President and Chief Executive Officer
  Principal Executive Officer



Date: July 31, 2018
  Sylvia Cheung
  Chief Financial Officer
  Principal Financial Officer


This certification shall not be deemed “filed” for any purpose, nor shall it be deemed to be incorporated by reference into any filing, under the Securities Act of 1933, as amended, or the Exchange Act.